Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.
Every day, find a selection of analysts' recommendations covering the main markets of North America and the U.K. The list includes only companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.
Amgen: Daiwa Securities downgrades to neutral from outperform. PT up 3% to $220
Apple: Tigress Financial raises Apple PT to $198 from $182, maintains Strong Buy rating
AstraZeneca: Credit Suisse retains its positive opinion on the stock with a Buy rating. The target price remains unchanged at GBp 9000.
AvalonBay: Goldman Sachs reinstated coverage with a recommendation of buy. PT raised 15% to $257